News & Publications

Representation of Luminera Derm in the Sale of its Dermal Business to AbbVie

Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]

Raz Tepper & Sharon Klein-Manbar & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Hila Zackay & Audrey Abensur & Moran Friedman | Oct 2020 | Transaction

Representation of Kitov Pharma in $35M Registered Direct Offering

Representation of Kitov Pharma Ltd. in a US$35M registered direct offering of shares represented by American Depositary Shares (ADSs) and warrants to purchase ADSs. H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering. Kitov Pharma Ltd. (NASDAQ/TASE: KTOV) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune […]

Raz Tepper & Sharon Rosen | Sep 2020 | Transaction

Special Update – Life Sciences & Healthcare – Israel Innovation Authority “Call for Proposals” re COVID-19

The Israel Innovation Authority published a “Call for Proposals” pursuant to which manufacturing companies are invited to submit applications for support in R&D plans or “pilots” offering technological innovation with respect to products and solutions for the prevention, treatment and challenges of the Corona Virus, until March 30, 2020 (at first stage). Please find the […]

Raz Tepper & Shmulik Fried | Mar 2020 | Legal Update

עדכון מיוחד – בריאות ומדעי החיים – “קול קורא” של רשות החדשנות לתוכניות להתמודדות עם נגיף הקורונה

רשות החדשנות בשיתוף עם משרד הכלכלה והתאחדות התעשיינים בישראל פרסמו “קול קורא” במסגרתו מוזמנות חברות תעשייתיות להגיש בקשות לקבלת סיוע לתוכניות מו”פ או תוכניות הרצה (“פיילוטים”), המהוות חדשנות טכנולוגית לפתרונות שנועדו למניעה, טיפול והתמודדות עם נגיף הקורונה, וזאת עד ליום 30 במרץ 2020 (כשלב ראשון). לקריאת העדכון המלא לחצו כאן

Raz Tepper & Shmulik Fried | Mar 2020 | Legal Update

Representation of AngioDynamics in the acquisition of Eximo Medical

FBC and DLA Piper represented AngioDynamics Inc., in an acquisition of Eximo Medical Ltd., an Israeli company. The transaction included extensive and sensitive negotiations of the terms and conditions of the acquisition from the various shareholders of Eximo Medical Ltd. and included the purchase of the company’s shares and treatment of the company’s options and […]

Raz Tepper & Sharon Klein-Manbar & Yuval Peled & Jonathan Shtang & Moran Friedman & Omri Rachum-Twaig, Dr. | Oct 2019 | Transaction

FBC represented OrbiMed in its $5,325,000 investment in MobileODT

FBC represented OrbiMed in its $5,325,000 investment in MobileODT Ltd. as part of a Series B Round of approximately $6,825,000 investment, in addition to conversion of SAFEs (“simple agreement for future equity”) in the amount of $3,905,223. The transaction included complex questions with regard to the applicability of the Israeli Securities Law and IP. MobileODT […]

Raz Tepper & Shmulik Fried | Jul 2017 | Transaction

FBC represented Applied Immune Technologies Ltd. in a complex merger transaction

FBC represented Applied Immune Technologies Ltd. (“AIT”), a drug development company specializing in therapeutic applications for cancer and other autoimmune diseases, owned by Technion Research and Development Foundation Ltd., Technion Investment Opportunities Fund, OrbiMed Israel Partners Limited Partnership, Novartis Bioventures Ltd., Pontifax funds and others, in a complex merger transaction for the purchase and sale […]

Raz Tepper & Ron Sitton | Jan 2016 | Transaction

Legal Update: FBC Represents Perrigo in its Rejection of Mylan’s Hostile Takeover Attempt

FBC represented Perrigo Company plc (“Perrigo”), a Dublin-based over-the-counter drug manufacturer traded on the New York Stock Exchange and the Tel Aviv Stock Exchange (“TASE”), as part of a global representation throughout the US, Ireland, the Netherlands and Israel, in Perrigo’s rejection of Mylan N.V.’s (“Mylan”) hostile takeover attempt, which ended with over 60% of […]

Raz Tepper & Avraham Well & Reuven Behar & Gil Orion, Dr. & Meital Ben-Basat & Tali Delouya & Jana Rabinovich | Nov 2015 | Legal Update

FBC advises Rainbow Medical in raising $25M from Chinese investors and in setting up a China office for strategic collaborations

FBC advises Rainbow Medical, a leading R&D and operational investment company, specializing in seeding and incubating medical device startups and developing breakthrough medical technologies, in raising $25 million from investors in China and opened a China office to promote strategic collaborations. “We opened the office in Shanghai to capitalize on China’s fast-growing market for our […]

Raz Tepper | Feb 2015 | Transaction

FBC advises the OrbiMed Fund in an investment in AtoxBio

FBC advises Orbimed in an investment in Atox Bio, a clinical stage company which develops novel immune-modulators for severe infections.

Raz Tepper | Aug 2014 | Transaction

FBC advises the OrbiMed Fund in an investment in Nucleix

FBC advises Orbimed in an investment in Nucleix, which develops a test for early detection of bladder cancer.

Raz Tepper | May 2014 | Transaction

FBC advises the Orbimed Fund in an investment in Keystone Heart

FBC advises Orbimed in an investment in Keystone Heart, which develops and manufactures embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.

Raz Tepper | May 2014 | Transaction

Underlying Legal and Regulatory Framework of Office of the Chief Scientist of the Israeli Ministry of the Economy

1. General  The Office of the Chief Scientist (“OCS”) of the Israeli Ministry of the Economy oversees all Israeli Government sponsored support of research and development (“R&D”) in the Israeli industry.[1] Pursuant to the Encouragement of Industrial Research and Development Law, 1984 and the regulations promulgated thereunder (the “R&D Law”),[2] the OCS provides Israeli companies […]

Raz Tepper | Jan 2014 | Publication

FBC advises the OrbiMed Fund, in a $6M private placement transaction in RedHill Biopharma

FBC advises the OrbiMed Fund, in a $6M private placement transaction in RedHill Biopharma, a public company dually listed on the NASDAQ and TASE.

Raz Tepper | Dec 2013 | Transaction

FBC advises Perrigo in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland

FBC advises Perrigo, a NYSE and TASE-traded company, in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland.

Raz Tepper & Sharon Rosen & Sharon Klein-Manbar & Itiel Ben-Haim | Dec 2013 | Transaction

FBC represents Kamada in Israeli aspects related to its $60M Nasdaq IPO

FBC represents Kamada in Israeli aspects related to its $60M Nasdaq IPO

Raz Tepper & Ronald Lehmann & Sharon Rosen | May 2013 | Transaction